BTIG Maintains Buy on ICU Medical, Raises Price Target to $200
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
BTIG analyst Sam Eiber maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $170 to $200.
BTIG analyst Sam Eiber maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $170 to $200.